Top Stories
A smart phone on a desk with Anthropic's Claude logo on the screen

Anthropic confidentially files for IPO: Here's what it means

Anthropic announced today that it had " confidentially submitted a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission for a proposed initial public offering of our common stock." An S-1 is the registration document a company files with regulators before it

A picture inside an empty theatre in Netflix's Tokyo office with Netflix logo on the screen

Netflix Stock Price Soars After Earnings Report Record New Memberships

Netflix stock price ( NASDAQ: NFLX ) is up more than 13% in the after-hours following its release of the fourth-quarter earnings report for fiscal year 2024. The streaming company recorded a 16% increase in revenue year-over-year, reaching 19% on a foreign exchange (F/X) neutral basis, which the

Latest News

Magnera Announces the Sale of Its Caerphilly, United Kingdom Operations

GlobeNewswire Inc.

CHARLOTTE, North Carolina, June 15, 2026 (GLOBE NEWSWIRE) -- Magnera Corporation (NYSE: MAGN) today announced the sale of its Caerphilly, UK operations to Polyart Group, a Prudentia Capital holding. Following a strategic portfolio review of its manuf

VAALCO Energy, Inc. Announces Exciting Operational Update in Offshore Gabon and in Egypt

GlobeNewswire Inc.

HOUSTON, June 15, 2026 (GLOBE NEWSWIRE) -- VAALCO Energy, Inc. (NYSE: EGY, LSE: EGY) (“Vaalco” or the “Company”) announced positive operational updates offshore Gabon regarding the ongoing drilling program, including impressive initial well results o

New Social Platform IFANN On The Rise As Rock Digital Launches Creator Rewards Program

Newsfile

Live since October 2025 and already counting hundreds of thousands of users, IFANN is being positioned as a serious contender for the long-promised "everything app" - and Rock Digital LLC is doubling down with the launch of a Creator Rewards Program

AD

Schneider Electric and Hon Hai Technology Group (Foxconn) announce strategic collaboration to accelerate next-generation AI data centers

GlobeNewswire Inc.

RUEIL-MALMAISON, France and TAIPEI, Taiwan, June 15, 2026 (GLOBE NEWSWIRE) -- Schneider Electric, a global energy technology leader, today announced a strategic collaboration with Hon Hai Technology Group (Foxconn), the world’s largest electronics ma

Cosmo Welcomes the Launches of Winlevi(R) in Austria and Germany

Newsfile

Dublin, Ireland and Heppenheim, Germany--(Newsfile Corp. - June 15, 2026) - Cosmo N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) is pleased to announce the launch of its innovative acne cream Winlevi® (clascoterone 1% cream) in Austria and Germany by its comm

Computex 2026: AMZFAST Expands Beyond Gaming Monitors with Smart Displays, OLED Technology and 400Hz Esports Performance

Newsfile

Taipei, Taiwan--(Newsfile Corp. - June 15, 2026) - At Computex 2026, AMZFAST unveiled its most ambitious display lineup to date, expanding beyond traditional gaming monitors into smart entertainment, premium OLED gaming, creator-focused displays, and

Haivivi Launches BubblePal AI Companion Toy, Bringing Warm and Screen-Free AI Interaction to Children

Newsfile

Shenzhen, China--(Newsfile Corp. - June 14, 2026) - As parents increasingly seek healthier alternatives to screen-based entertainment, Haivivi has officially launched BubblePal, an innovative AI-powered companion toy designed to transform ordinary pl

Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress

GlobeNewswire Inc.

Poster presentations from ongoing clinical trials of two core assets, olverembatinib and lisaftoclax, highlight global innovation capabilities in hematologic malignancies ROCKVILLE, Md. and SUZHOU, China, June 14, 2026 (GLOBE NEWSWIRE) -- Ascentage P

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026

GlobeNewswire Inc.

ZW191 demonstrates compelling anti-tumor activity in platinum-resistant ovarian cancer patients regardless of FRα expression levelConfirmed objective response rate (cORR) of 78.6% in FRα-positive (≥75% at PS2+) platinum-resistant ovarian cancer patie

Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026

GlobeNewswire Inc.

Data show investigational atumelnant drove sustained androgen reductions while enabling lowering of glucocorticoid supplementation to physiologically normal levels in adults with classic CAH New results from the Phase 1b/2a ACTH-dependent Cushing’s s

AD